A slightly lower proportion of CD5+ DLBCL cases were BCL6-positive compared with CD5- DLBCL, although the difference was not statistically significant (58.3% vs. 82.6%, P = 0.069). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.